Type 1 Diabetes

>

Latest News

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Committee Casts Negative Vote on Sotagliflozin in Type 1 Diabetes

November 2nd 2024

The 11 to 3 vote against the benefit-risk profile of sotagliflozin comes with less than 2 months to go until the December 20, 2024 PDUFA date.

HCPLive Endocrinology Month in Review September 2024 thumbnail
Endocrinology Month in Review: September 2024

October 6th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Clears Eversense 365, Marking First 1-Year CGM Option in Diabetes

September 18th 2024

HCPLive Endocrinology Month In Review August 2024
Endocrinology Month in Review: August 2024

September 10th 2024

Brian Callaghan, MD, MS | Credit: Michigan Medicine
Study Finds Diabetes Complications and Mental Health Disorders Are a 2-Way Street

August 27th 2024

Video Interviews
Podcasts
Brian Hansen | Credit: Ascensia Diabetes Care
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Carol Levy, MD | Credit: T1D Exchange

More News

© 2024 MJH Life Sciences

All rights reserved.